Function Health
Provides a membership-based preventive health platform using comprehensive lab testing to help consumers track and manage health risks.
Overview
Function Health builds a consumer preventive-care platform centered on broad lab testing, longitudinal health tracking and personalized insights. Its target market is individuals seeking earlier visibility into health risks before acute or chronic conditions become costly. The company differentiates around a proactive model that aims to show preventive care can be less expensive than waiting for illness to develop. It has raised $450 million in a growth round from General Catalyst, positioning the business to scale its model and validate preventive care economics.
Funding History
Function Health nets $450M from General Catalyst to prove preventive care is cheaper than waiting to get sick
Frequently Asked Questions
- How much funding does AI Funding track for Function Health?
- AI Funding tracks $450M for Function Health across 1 funding round in this database.
- Who are Function Health's investors?
- Function Health's investors include General Catalyst.
- What does Function Health do?
- Function Health builds a consumer preventive-care platform centered on broad lab testing, longitudinal health tracking and personalized insights. Its target market is individuals seeking earlier visibility into health risks before acute or chronic conditions become costly. The company differentiates around a proactive model that aims to show preventive care can be less expensive than waiting for illness to develop. It has raised $450 million in a growth round from General Catalyst, positioning the business to scale its model and validate preventive care economics.
- Where is Function Health headquartered?
- Function Health is headquartered in Austin, United States.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.